Partnership Forum: Participants discussed how digital therapeutics with web and designed based applications are emerging as a means to treat conditions by engaging people to improve health and wellness.
AMCP Digital Therapeutics Advisory Group
Introduction:
The role of digital therapeutics in preventing, managing, and treating medical conditions continues to evolve, offering the potential for therapeutic benefit. AMCP is committed to leveraging managed care pharmacy to continue to evolve the use of digital therapeutics to improve patient care and outcomes. This group will build upon the recommendations put forth during the previous AMCP Partnership Forums and provide guidance to AMCP in its efforts to establish the leadership role of managed care pharmacy professionals in this area, identify potential partners, and assist in the creation and dissemination of tools and resources to enhance the coverage and utilization of digital therapeutics.
AMCP Collaborate Interest Group:
This online community, available only to AMCP members, will serve as a space to spark conversation, share ideas, and ask questions on all things Digital Therapeutics. Sign up here to join the conversation.
The work of this advisory group is supported by Akili Interactive, Mahana Therapeutics, MetaMe Health, Pear Therapeutics, Pfizer, PhRMA, Otsuka, and Xcenda.
Related
This advisory group was active from March 2021-June 2022.
This advisory group was active from April 2021-March 2022.
Featured News & Resources
See Full CalendarUpcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
